Table 3.
Factors Predicting the Non-Adherence to Imatinib (n=89)
| Variables | Univariate Analysis | Multiple Logistic Regression | ||||||
|---|---|---|---|---|---|---|---|---|
| b | Crude OR | 95% CI | p-Value | b | Adj OR | 95% CI | p-Value | |
| Age | −0.02 | 0.98 | 0.94–1.01 | 0.184 | −0.07 | 0.93 | 0.89–0.98 | 0.007 |
| Living with family | 1.21 | 3.36 | 0.62–18.33 | 0.162 | ||||
| Presence of comorbidities | 0.59 | 1.80 | 0.78–4.20 | 0.171 | 1.52 | 4.56 | 1.44–14.40 | 0.010 |
| Presence of ADR | 1.32 | 3.75 | 1.54–9.14 | 0.004 | ||||
| Presence of nausea and vomiting | 1.57 | 4.78 | 1.46–15.70 | 0.010 | 1.73 | 5.63 | 1.25–25.27 | 0.024 |
| Presence of skin rash | 1.69 | 5.44 | 0.63–47.23 | 0.124 | ||||
Abbreviations: OR, odds ratio; CI, confidence interval; Adj OR, adjusted odds ratio; ADR, adverse drug reaction.